Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells
Mylène Honorat(Centre Léon Bérard), Léa Payen(Université Claude Bernard Lyon 1), Charles Dumontet(Centre de Recherche en Cancérologie de Lyon), Pascale A. Cohen(Lyon 1 Université), Attilio Di Pietro(Lyon 1 Université), Valerie C. L. Lin(Nanyang Technological University), Aurélia Mesnier(Lyon 1 Université)
Cited by 47
Related Papers
Antibody–drug conjugates come of age in oncology
|Nature Reviews Drug Discovery|2023|772
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach
|Endocrine Related Cancer|2006|239
Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
|Recent Patents on Anti-Cancer Drug Discovery|2009|162